Related Experiment Video

Updated: Jul 16, 2026

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
14:19

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction

Published on: June 29, 2013

[Risk factors associated with intrauterine growth delay]

Cristhian Arriola-Ortiz1, Genaro Vega-Malagón, Adrián Hernández-Lomelí

  • 1Hospital del Niño y la Mujer, and Universidad Autónoma de Querétaro, Facultad de Medicina, Departamento Clínico, Mexico.

Revista Medica Del Instituto Mexicano Del Seguro Social
|March 10, 2007
PubMed

Insights

Intrauterine growth delay (IGD) affects 2.5% of newborns, with risk factors including inadequate maternal weight gain and insufficient prenatal care. Early detection and intervention are crucial for reducing newborn morbidity and mortality.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Health
  • Perinatal Medicine

Context:

  • Intrauterine growth delay (IGD) is defined as a birth weight below the 10th percentile for gestational age.
  • This study investigated IGD prevalence and risk factors in newborns with normal fetal growth curves.
  • The research was conducted at General Hospital in Queretaro, Queretaro.

Purpose:

  • To determine the prevalence of intrauterine growth delay (IGD).
  • To identify risk factors associated with IGD in patients with normal fetal growth curves.
  • To provide insights for improving prenatal care and reducing adverse neonatal outcomes.

Summary:

  • A prevalence of 2.5% for intrauterine growth delay (IGD) was observed.
  • Key risk factors identified include inadequate maternal weight gain (OR 4.84), fewer than five prenatal appointments (OR 6.0), hypertensive disorders (OR 5.09), and cervicovaginal infections (OR 5.09).
  • Maternal age (below 20 or above 30) did not show significant differences in association with IGD.

Impact:

  • Highlights the importance of adequate prenatal care and monitoring for pregnant women, especially teenagers.
  • Emphasizes the need for early detection of risk factors to mitigate newborn morbidity and mortality.
  • Provides evidence-based information for healthcare providers to refine IGD prevention and management strategies.
Abstract

More Related Videos

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...